DISCLOSEDQuarterly
Renaissance Technologies
Karyopharm Therapeutics Inc · NASDAQ
105,414 sh · $587.2K
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Karyopharm Therapeutics Inc · NASDAQ
105,414 sh · $587.2K
Two Sigma Investments
Karyopharm Therapeutics Inc · NASDAQ
151,232 sh · $842.4K